Biosite to assess TpP (thrombosis precursor protein) marker for POC (point-of-care) Triage platform
This article was originally published in Clinica
Executive Summary
Biosite is to investigate the possibility of incorporating American Biogenetic Sciences' (ABS) thrombus precursor protein (TpP) monoclonal antibodies on its point-of-care (POC) Triage meter testing platform.